NFX UK’s $650,000 boost signals a new era for novel foods regulation

Posted 13 July, 2026
Share on LinkedIn

The $650,000 investment into NFX UK is an accelerant designed to strengthen the UK’s regulatory infrastructure for novel foods, unlock faster commercialisation pathways, and extend the UK’s influence into Europe’s emerging protein diversification landscape. 

Why this funding matters

The investment from Coefficient Giving gives NFX UK the resources to scale a model that has already demonstrated national impact. The funding enables three critical advances:

  1. Strengthening the UK’s regulatory readiness — expanding support for innovators preparing novel foods dossiers and navigating regulatory complexity.
  2. Deepening ecosystem coordination — accelerating collaboration between industry, regulators, researchers and government.
  3. Launching European expansion — applying the UK-tested model to support the EU’s growing alternative protein and engineering biology agenda. This is the creation of a more predictable, innovation‑friendly regulatory environment that can unlock commercialisation at pace.

The systemic challenge NFX UK is built to solve

Novel foods innovation — from cell‑cultivated products to precision fermentation — is advancing rapidly. But regulatory pathways have not kept pace.

Key barriers include:

  • Complex, resource‑intensive novel foods dossier preparation
  • Limited regulatory engagement opportunities for early‑stage companies
  • Fragmented ecosystem knowledge and inconsistent regulatory understanding
  • Slow translation of scientific breakthroughs into market-ready products

NFX UK was created to address these barriers head-on through three interconnected pillars: ecosystem building; regulatory engagement; knowledge exchange.

Since September 2025, the network has engaged stakeholders across 14 countries, built a community of 260+ organisations and individuals, facilitated 15+ structured regulator engagement activities and established trusted two-way dialogue with FSA and FSS.

This track record demonstrates that NFX UK is not just a convenor — it is an operational engine for regulatory innovation.

What the $650,000 investment unlocks

The funding enables NFX UK to scale its proven model and deliver impact across two fronts:

1. Deepening UK impact

  1. More support for innovators preparing regulatory dossiers
  2. Expanded regulator–industry engagement programmes
  3. Strengthened knowledge-sharing infrastructure
  4. Greater alignment with UK Government engineering biology priorities

2. European expansion

  • Establishing NFX UK’s first EU presence
  • Supporting Europe’s protein diversification agenda
  • Creating cross-border regulatory learning pathways
  • Laying foundations for a broader international expansion strategy

This positions the UK as a global leader in regulatory excellence, exporting its approach to markets seeking clarity, speed and scientific rigour.

Leadership perspectives

Jacinta George, managing director and VP at RSSL said the ambition is to make the UK the world’s leading environment for responsible novel food innovation.

“This investment allows us to scale what we have built and strengthen our role in accelerating faster, higher-quality and more responsible regulatory approvals in the UK, across Europe and, ultimately, worldwide,” George said.

Abhi Kumar, associate programme officer at Coefficient Giving said: “NFX UK’s combination of scientific expertise and ecosystem leadership makes it a strong partner for driving systemic change… We are excited to support NFX UK’s work to strengthen regulatory readiness, foster collaboration and help translate scientific innovation into real-world impact.”

Why this signals a turning point for the sector

This funding is significant because it shifts the UK’s novel foods landscape from individual company progress to system-level capability building. It strengthens the infrastructure required for responsible innovation, faster approvals and international competitiveness. It also aligns directly with the UK’s engineering biology ambitions — positioning the country as a regulatory leader at a time when global demand for alternative proteins and sustainable food systems is accelerating.

 

Read more